Erectile dysfunction (ED) is a common condition in men with cardiovascular disease (CVD), yet it is frequently under-recognized and under-diagnosed in clinical practice. Men are often reluctant to seek treatment, even though they have lower sexual and overall life satisfaction compared with healthy people. Moreover, moderate ED has a similar impact on a patient's satisfaction with sexual life as severe ED. Both patient-and physician-related factors contribute to the underdiagnosis and under-recognition of ED. A holistic, patient-centered approach is fundamental to the management of ED in men with CVD. Sexual medical training courses can enhance physicians' communication skills. Implementing lifestyle changes, recognizing the factors that lead to poor compliance and reducing psychologic stress can also lead to improvements in the management of ED. As ED and CVD share similar risk factors, a common prevention strategy has been proposed.
Introduction
Erectile dysfunction (ED) is a prevalent condition in men with cardiovascular disease (CVD), 1 and may also be a silent marker for atherosclerosis. 2, 3 Baseline data from the prospective pan-European Erectile Dysfunction Observational Study, which provides information on the profiles of patients seeking treatment for ED, identified CVD as a common comorbidity. 4 A total of 8055 patients (mean age 56.5 years), enrolled by 904 investigators from nine European countries, were eligible for analysis at baseline. Approximately 25% of these patients had a history of CVD (in the past 6 months) and 23% had diabetes. Many patients were also receiving concomitant cardiovascular medications: 33.8% antihypertensives, 18.8% lipid-lowering agents and 11.6% other cardiovascular medications. Furthermore, results from this naturalistic setting identified a large unmet need, with 66% of patients having experienced ED symptoms for more than 1 year before they sought treatment.
The effect of disease on the risk of ED was assessed in the Massachusetts Male Aging Study, a longitudinal study of health status and aging in a randomly selected cohort of Boston men (aged 40-70 years). 5 After an average follow-up of 8.8 years, the incidence of ED overall was 26 cases per 1000 man-years; however, in patients with hypertension, diabetes or heart disease, the incidence rates were markedly higher, at 42.5, 50.7 and 58.3 cases per 1000 man-years, respectively.
There are a number of treatment options for patients with ED, from oral therapies to penile implants. [6] [7] [8] The availability of the oral phosphodiesterase type 5 inhibitors, sildenafil, tadalafil and vardenafil, means that there are a number of first-line treatment options for patients with ED. 9 However, ED is frequently under-recognized and under-diagnosed in clinical practice. 1 The reasons for this include patient-and physician-related factors, as well as the lack of a care model for the management of ED. This article discusses the factors that lead to the under-recognition and underdiagnosis of ED, management challenges and the need for a holistic approach to managing ED in patients with CVD.
Why is ED under-diagnosed and under-treated?
Patient-related factors A barrier to diagnosis of ED is the reluctance of a large proportion of men to seek treatment. For example, in a study of 9536 men with sexual concerns who called a helpline over a 5-year period, 5164 had ED, but only 1903 men (36.9%) had ever consulted a doctor. 10 Results from a survey of 639 men in the United States conducted by the American Association of Retired Persons revealed that only 10% reported seeking or receiving treatment for 'sexual problems. ' 1 This reluctance may be because of embarrassment or a lack of understanding of the disease or its available treatments.
Men who seek help for ED have significantly lower satisfaction with both their sexual life (Po0.001) and overall life (P ¼ 0.007) than the healthy population, according to results from a study at an andrology outpatient clinic (Figure 1 ). 11 Interestingly, compared with healthy individuals, men with ED had significantly higher satisfaction in other domains of their life (Po0.001; Figure 1 ), possibly reflecting coping behaviors that help compensate for their low overall life satisfaction. The severity of ED was significantly negatively correlated with patients' satisfaction with sexual life (Po0.001); however, there was no significant difference depending on the severity in any of the other domains or in the total satisfaction assessed.
A number of factors that prompt patients to seek treatment have been identified. For example, in a study of male callers to a sexual concerns helpline, the duration of ED was significantly associated with a willingness to seek medical help (Po0.001). 10 In addition, organic comorbidities were significantly associated with prior consultation with a doctor in patients with ED (Po0.05). Partners can also be instrumental in seeking help: analysis of calls made by 2287 women to the same helpline revealed that nearly half (46.6%) were motivated to seek help regarding a partner's sexual problems. 12 Physician-related factors Sexual health is an integral part of patients' overall health, and can be considered to encompass aspects of physical, emotional, mental and social wellbeing. 13 However, physicians do not always address all relevant aspects when taking a patient's sexual health history, and typically approach the management of chronic illnesses, such as ED and CVD, from a disease-centered perspective.
14 This approach is frequently inadequate, and the fundamental need for a patient-centered approach in managing individuals with sexual problems has been emphasized. 15, 16 One of the key factors of such an approach is the appropriate taking of sexual history, something that can pose difficulties for clinicians. One of the barriers has been identified as a lack of appropriate training. Indeed, prior training in communication skills has been identified as the strongest predictor for sexual history taking. 17 Other predictors of physicians' involvement in addressing sexual health issues include an interest in psychosocial factors and liberal sexual attitudes. Urologists and cardiologists are also more likely to be involved in sexual history taking than internists and general practitioners.
The benefits of setting up sexual medicine training courses for physicians have been highlighted in a recent study. 18 Following a pilot workshop on the management of ED, there was a shift in physicians' attitudes toward a more patient-centered approach, as shown by a significant increase in the total Patient-Practitioner Orientation Scale (Po0.05) and the shared decision-making subscale (Po0.05). Physicians' sexual attitudes were also more liberal after the workshop, according to the Cross Cultural Attitude Scale (Po0.001). A tutorial session on the 'medical treatment of ED' received the highest evaluation score for the acquisition of new knowledge and usefulness (Po0.001).
Challenges in managing ED and CVD
The diagnosis of chronic illnesses such as CVD and ED can be distressing for patients and their families.
14 A diagnosis of either condition requires physical and psychologic adjustment by both patients and their partners, as they adapt to the chronic nature of heart disease and consequent changes in their sex lives.
Modifying lifestyle
It can be noted that ED and CVD share a number of major risk factors, including age, dyslipidemia, hypertension, diabetes, smoking, sedentary lifestyle, obesity and depression. 19 Patients should be aware of these risk factors and of the distinction between fixed and modifiable risk factors, showing that lifestyle changes can improve both sexual function and CVD risk. Individuals' response to erectile dysfunction D Hatzichristou
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The effect of midlife lifestyle changes on the risk of ED has been prospectively examined in the Massachusetts Male Aging Study. 20 After a followup of 8.8 years in men initially aged 40-70 years, no significant improvements in risk of ED were noted through reducing smoking, obesity or alcohol consumption, suggesting that earlier risk factors may lead to irreversible increase of risk. However, men who were initially active or even those who initiated moderate or vigorous physical exercise during the study period were at a significantly reduced risk of ED. Thus, although adoption of a healthier lifestyle is clearly desirable, exercise even in older men appears to be of benefit.
Regular exercise in older adults has beneficial effects on the cardiovascular system; it improves glycemic control, neuropsychological health and osteoarthritis, and decreases the risk of cancer, osteoporosis and all-cause morbidity and mortality. 21 However, up to 75% of older American adults do not exercise sufficiently to achieve these health benefits. 21 Improving compliance Even when patients do seek treatment, compliance with prescribed medication can be poor; for a broad range of chronic diseases, compliance has been estimated to be of the order of 50%. 22 There has been extensive research into the reasons or predictors for non-compliance, and although literally hundreds of factors have been examined, no consistent predictors have been found to be generally applicable. 22 However, a number of factors have been identified, including duration and complexity of the prescribed behavior change, cultural attitudes and characteristics of the health professional (for example, empathy of the provider; extent to which the professionals elicit confidence in their competence). The impact of the drug itself on a patient's lifestyle may also affect compliance. 23 Patients are less likely to adhere to a treatment that is either inconvenient or that has substantial perceived inconvenient effects on their day-to-day life.
Depression, which is common in patients with CVD and in patients with ED, can have a further impact on adherence to chronic treatment. In a cross-sectional study of 496 hypertensive patients, depression was found to be significantly associated with non-compliance to antihypertensive medication (adjusted odds ratio (per point increase on a 14-point scale): 0.93; 95% confidence interval 0. 87-0.99; P ¼ 0.027). 24 Psychosocial factors such as patients' knowledge of hypertension, health beliefs and satisfaction with care were not associated with compliance. In a cohort study of 153 hospitalized patients interviewed 4 months after discharge, older post-myocardial infarction patients (X65 years) with depression were less likely to adhere to medication or modify their diet and exercise regularly than patients without depression. 25 ED, depression and CVD frequently co-occur and appear to share a number of risk factors; on this basis, a mutually reinforcing triad of the diseases has been proposed to play a significant role, increasing mortality and affecting the quality of life dramatically (Figure 2 ). 26 Reducing stress Emotional stress has a negative effect on the cardiovascular system. 27 Long-term exposure to increased levels of catecholamines can cause increases in heart rate and blood pressure. Chronic emotional stress is mainly dependent on broad personality traits: individuals who tend to experience negative emotions and simultaneously inhibit emotions and behaviors in social situations have been designated as having a 'distressed' or 'type D' personality, and this appears to be a risk factor for negative effects of stress. 28 In a prospective 5-year follow-up study of 319 patients with coronary heart disease, a type D personality was shown to be associated with an increased risk of cardiac events, despite appropriate treatment (P ¼ 0.0001). 28 Type D personality was also associated with a poor quality of life (P ¼ 0.0001).
The need for a patient-centered care model for ED management
The involvement and inter-relationships of the factors discussed, including CVD, psychologic and erectile symptoms, show that a holistic, patientcentered approach is needed to address patients' conditions adequately, both from the physician's and the patient's perspective. Individuals' response to erectile dysfunction D Hatzichristou
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Patients' role in managing health and symptom perception A report by the Institute of Medicine has highlighted the chasm between the health care available and that sought by patients. 29 Rather than simply receiving services appropriate to their needs, patients often have to adapt to customs and procedures of healthcare professionals. 29 The role of ED patients in managing their health has been underestimated and undervalued as a critical component of health outcomes.
Understanding patients' perception of symptoms may have important implications for health outcomes. Patients most commonly seek medical help when they experience a symptom. However, symptom perception is complex; physical symptoms are stimuli that are subject to psychologic and social influences, 30 and hence people who experience a symptom with a similar frequency and severity may not feel the same level of concern over it. This, therefore, affects whether they seek help, the sort of information they provide to the health-care professional, and their treatment needs. The 'illness iceberg' concept by John Last likens the symptoms, as described to a physician, to 'the tip of an iceberg.' Some patients may present with symptoms but not receive a diagnosis. Patients may choose to treat the symptoms themselves, or may not even realize that they have a symptom. Unfortunately, there is as yet no biopsychosocial model that integrates the totality of peoples' response to symptoms, including their perception of symptoms, their help-seeking behavior, and the outcome.
Prevention strategy for ED and CVD Cardiologists, urologists and family physicians commonly treat patients with CVD and ED; as both conditions share similar risk factors, a common prevention and management strategy would be of potential benefit. Such a strategy has been proposed recently, considering not only the patients' medical and psychosexual history, but also the individual needs and expectations (Figure 3 ).
14 This model describes a patient-centered approach for the management of these chronic conditions and includes four features: (a) identification of patients' needs and expectations, (b) provision of education and counseling to both patient and partner, (c) shared decision-making and (d) reevaluation/adaptation of treatment strategy. This is a fundamental approach to the prevention and management of ED in men with and without CVD.
One reason for proposing such an integrated approach is that CVD has not only medical but also serious emotional and behavioral consequences for patients. In contrast, erectile function involves a complex series of interactions between behavioral, emotional and physiologic factors. Even minor perturbations of any of these factors (typically seen in CVD patients) may result in ED. The availability of phosphodiesterase type 5 inhibitors, as well as public advertisements of these new oral drugs have increased the number of patients seeking treatment for ED. One impact of increasing patient numbers is that physicians with different specialties (for example, family physicians, cardiologists and urologists), but without a detailed background knowledge and clinical experience in the field of sexual medicine, have become more involved in ED therapy. For such physicians, a simplistic diagnostic and treatment approach may be desirable. This typically includes three phases: (a) identification of the sexual problem (in a few cases by the self-administered International Index of Erectile Function questionnaire), (b) prescription of one of the phosphodiesterase type 5 inhibitors and (c) for patients not responding to an oral agent, some physicians will refer their patients to experts for second-and third-line treatment (intracavernosal injection therapy and penile prosthesis implantation, respectively), whereas most physicians will prescribe another phosphodiesterase type 5 inhibitor.
However, is such a simplistic management strategy appropriate for CVD patients with ED? Furthermore, should we offer the same treatment options to a patient with psychogenic ED after a heart attack and to a patient with vasculogenic ED owing to CVD? The answer to this question should be definitely not. Besides biomedical aspects, the physician also needs to address three issues:
Patient's preference for care. Patients vary in their preferences concerning their consultation in at least two aspects: (a) what they want to discuss with their doctor and (b) their preferred level of involvement in decision making. Therefore, physicians will need to take into account the patients' level of willingness to participate in the decision-making process.
Psychosocial factors may explain patients' variance to their response to treatment options. For example, the patient's emotional status, his level of understanding of the condition, his current life stressors and so on. The possible influence of these issues on the maintenance or treatment of ED needs to be addressed during consultation.
Factors related to the partner and the relationship may also be considered. Partner's sexual dysfunction or relationship factors, such as the level of communication or the presence of conflict, are issues that need to be included in the management strategy. Furthermore, many partners of patients with a history of CVD are afraid to resume sexual activity in case this leads to a heart attack; thus, the physician should also be prepared to deal with this fear and provide counseling, as most sexual partners will have a sense of guilt and shame to discuss it. As all these factors may cause or maintain the presenting ED, treatment outcome will be optimal only when these are integrated into the management strategy.
Conclusions
An understanding of the patient-and physicianrelated factors that are a barrier to the diagnosis and treatment of ED is important in improving the management of this common condition in men with CVD. The beneficial effects of lifestyle modification, improving compliance and reducing emotional stress are recognized, and a more holistic approach using a patient-centered model will be more effective in addressing individuals' needs. Adopting such an approach can lead to an increase in the recognition and diagnosis of ED, and improve treatment outcomes and patients' lives.
